Acro Biomedical (ACBM) Cash & Equivalents Growth (5y) (2020 - 2025)
Acro Biomedical (ACBM) Cash & Equivalents Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.72% |
| Sep 30, 2025 | 94.33% |
| Jun 30, 2025 | -41.55% |
| Mar 31, 2025 | -52.73% |
| Dec 31, 2024 | -12.18% |
| Sep 30, 2024 | -13.79% |
| Jun 30, 2024 | 32.01% |
| Mar 31, 2024 | -18.19% |
| Dec 31, 2023 | -60.19% |
| Sep 30, 2023 | 23.30% |
| Jun 30, 2023 | -10.30% |
| Mar 31, 2023 | -76.73% |
| Dec 31, 2022 | -7.29% |
| Sep 30, 2022 | -15.15% |
| Dec 31, 2021 | 108.96% |
| Sep 30, 2021 | 127.59% |
| Jun 30, 2021 | 151.51% |
| Mar 31, 2021 | 25.77% |
| Dec 30, 2020 | 2.64% |
| Sep 30, 2020 | -64.40% |